COMy 2019 | How are treatment practices changing in Waldenström’s?

Steven Treon

Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses changing practices in Waldenström’s Macroglobulinemia, including novel targets for therapy. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video